Alena A Semenova

Ms. Alena A Semenova

Mari State University
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
Mikhail DubininMikhail Dubinin
Mikhail Dubinin
IMIrina Mikheeva
Irina Mikheeva
ASAnastasia Евгеньевна Anastasia E. Stepanova
Anastasia Евгеньевна Anastasia E. Stepanova
AIAnastasia Igoshkina
Anastasia Igoshkina
ACAlena A. Cherepanova
Alena A. Cherepanova
Konstantin N. BelosludtsevKonstantin N. Belosludtsev
Konstantin N. Belosludtsev
Duchenne muscular dystrophy is caused by loss of the dystrophin protein. This pathology is accompanied by mitochondrial dysfunction contributing to muscle fiber instability. It is known that mitochondria-targeted in vivo therapy mitigates pathology and improves the quality of life of model animals. In the present work, we applied mitochondrial transplantation therapy (MTT) to correct the pathology in dystrophin-deficient mdx mice. Intramuscular injections of allogeneic mitochondria obtained from healthy animals into the hind limbs of mdx mice alleviated skeletal muscle injury, reduced calcium deposits in muscles and serum creatine kinase levels, and improved the grip strength of the hind limbs and motor activity of recipient mdx mice. We noted normalization of the mitochondrial ultrastructure and sarcoplasmic reticulum/mitochondria interactions in mdx muscles. At the same time, we revealed a decrease in the efficiency of oxidative phosphorylation in the skeletal muscle mitochondria of recipient mdx mice accompanied by a reduction in lipid peroxidation products (MDA products) and reduced calcium overloading. We found no effect of MTT on the expression of mitochondrial signature genes (Drp1, Mfn2, Ppargc1a, Pink1, Parkin) and on the level of mtDNA. Our results show that systemic MTT mitigates the development of destructive processes in the quadriceps muscle of mdx mice.

10 May 2021 in Membranes
Verified
Journal Article
Open access
PDF file
Mikhail DubininMikhail Dubinin
Mikhail Dubinin
ASAlena A Semenova
Alena A Semenova
DNDarya Nedopekina
Darya Nedopekina
EDEldar Davletshin
Eldar Davletshin
Anna SpivakAnna Spivak
Anna Spivak
Konstantin N. BelosludtsevKonstantin N. Belosludtsev
Konstantin N. Belosludtsev
This work demonstrates the effects of a newly synthesized conjugate of the plant triterpenoid betulin and the penetrating cation F16 used for mitochondrial targeting. The resulting F16-betulin conjugate revealed a mitochondria-targeted effect, decreasing the mitochondrial potential and inducing superoxide overproduction in rat thymocytes in vitro. It has been suggested that this may cause the cytotoxic effect of the conjugate, which significantly exceeds the effectiveness of its precursors, betulin and F16. Using isolated rat liver mitochondria, we found that the F16-betulin conjugate has a surface-active effect on mitochondrial membranes, causing organelle aggregation. This effect of the derivative resulted in a dose-dependent decrease in mitochondrial transmembrane potential, as well as suppression of respiration and oxidative phosphorylation, especially in the case of nicotinamide adenine dinucleotide (NAD)-fueled organelles. In addition, the F16-betulin conjugate caused an increase in H2O2 generation by mitochondria fueled with glutamate and malate. These effects of the derivative can presumably be due to the powerful suppression of the redox activity of complex I of the mitochondrial electron transport chain. The paper discusses how the mitochondria-targeted effects of the F16-betulin conjugate may be related to its cytotoxic effects.

30 May 2023 in Membranes
Verified
Journal Article
Open access
PDF file
Mikhail DubininMikhail Dubinin
Mikhail Dubinin
DNDarya Nedopekina
Darya Nedopekina
AIAnna I. Ilzorkina
Anna I. Ilzorkina
ASAlena A Semenova
Alena A Semenova
VSVyacheslav A. Sharapov
Vyacheslav A. Sharapov
Konstantin N. BelosludtsevKonstantin N. Belosludtsev
Konstantin N. Belosludtsev
The present work shows the cytotoxic effects of novel conjugates of ursolic, oleanolic, maslinic, and corosolic acids with the penetrating cation F16 on cancer cells (lung adenocarcinoma A549 and H1299, breast cancer cell lines MCF-7 and BT474) and non-tumor human fibroblasts. It has been established that the conjugates have a significantly enhanced toxicity against tumor-derived cells compared to native acids and also demonstrate selectivity to some cancer cells. The toxic effect of the conjugates is shown to be due to ROS hyperproduction in cells, induced by the effect on mitochondria. The conjugates caused dysfunction of isolated rat liver mitochondria and, in particular, a decrease in the efficiency of oxidative phosphorylation, a decrease in the membrane potential, and also an overproduction of ROS by organelles. The paper discusses how the membranotropic- and mitochondria-targeted effects of the conjugates may be related to their toxic effects.

28 April 2023 in Membranes
Verified
Journal Article
Open access
PDF file
VSVictor N. Samartsev
Victor N. Samartsev
EKEkaterina I. Khoroshavina
Ekaterina I. Khoroshavina
EPEvgeniya K. Pavlova
Evgeniya K. Pavlova
Mikhail DubininMikhail Dubinin
Mikhail Dubinin
ASAlena A Semenova
Alena A Semenova
It is now generally accepted that the role of bile acids in the organism is not limited to their participation in the process of food digestion. Indeed, bile acids are signaling molecules and being amphiphilic compounds, are also capable of modifying the properties of cell membranes and their organelles. This review is devoted to the analysis of data on the interaction of bile acids with biological and artificial membranes, in particular, their protonophore and ionophore effects. The effects of bile acids were analyzed depending on their physicochemical properties: namely the structure of their molecules, indicators of the hydrophobic–hydrophilic balance, and the critical micelle concentration. Particular attention is paid to the interaction of bile acids with the powerhouse of cells, the mitochondria. It is of note that bile acids, in addition to their protonophore and ionophore actions, can also induce Ca2+-dependent nonspecific permeability of the inner mitochondrial membrane. We consider the unique action of ursodeoxycholic acid as an inducer of potassium conductivity of the inner mitochondrial membrane. We also discuss a possible relationship between this K+ ionophore action of ursodeoxycholic acid and its therapeutic effects.

27 February 2022 in Biology
Verified
Journal Article
Open access
PDF file
Natalia V. BelosludtsevaNatalia V. Belosludtseva
Natalia V. Belosludtseva
VSVlada S. Starinets
Vlada S. Starinets
ASAlena A Semenova
Alena A Semenova
AIAnastasia Igoshkina
Anastasia Igoshkina
Mikhail DubininMikhail Dubinin
Mikhail Dubinin
Konstantin N. BelosludtsevKonstantin N. Belosludtsev
Konstantin N. Belosludtsev
S-15176 difumarate salt, a derivative of the anti-ischemic metabolic drug trimetazidine, has been intensively studied for its impact on cellular metabolism in animal models of ischemia-reperfusion injury of the liver, heart, spinal cord, and other organs. Despite evidence of some reduction in oxidative damage to cells, the results of therapy with S-15176 have been mostly disappointing, possibly because of the lack of data on its underlying mechanisms. Here, we aimed to investigate in more detail the role of complexes I-IV of the electron transport chain and membrane permeability transition in mitochondrial toxicity associated with S-15176. Using rat thymocyte and liver mitochondria, we demonstrated that: (1) acute exposure to S-15176 (10 to 50 μM) dose-dependently decreased the mitochondrial membrane potential; (2) S-15176 suppressed the ADP-stimulated (State 3) and uncoupled (State 3UDNP) respiration of mitochondria energized with succinate or malate/glutamate, but not ascorbate/TMPD, and increased the resting respiration (State 4) when using all the substrate combinations; (3) S-15176 directly inhibited the activity of the respiratory complex III; (4) low doses of S-15176 diminished the rate of H2O2 production by mitochondria; (5) at concentrations of above 30 μM, S-15176 reduced calcium retention capacity and contributed to mitochondrial membrane permeabilization. Taken together, these findings suggest that S-15176 at tissue concentrations reached in animals can impair mitochondrial function through suppression of the cytochrome bc1 complex and an increase in the nonspecific membrane permeability.

8 September 2022 in Membranes
Verified
Journal Article
Open access
PDF file
Mikhail DubininMikhail Dubinin
Mikhail Dubinin
VSVyacheslav A. Sharapov
Vyacheslav A. Sharapov
ASAlena A Semenova
Alena A Semenova
Lyudmila ParfenovaLyudmila Parfenova
Lyudmila Parfenova
AIAnna I. Ilzorkina
Anna I. Ilzorkina
Konstantin N. BelosludtsevKonstantin N. Belosludtsev
Konstantin N. Belosludtsev
This paper demonstrates the membranotropic effect of modified levopimaric acid diene adducts on liver mitochondria and lecithin liposomes. We found that the derivatives dose-dependently reduced the efficiency of oxidative phosphorylation of mitochondria due to inhibition of the activity of complexes III and IV of the respiratory chain and protonophore action. This was accompanied by a decrease in the membrane potential in the case of organelle energization both by glutamate/malate (complex I substrates) and succinate (complex II substrate). Compounds 1 and 2 reduced the generation of H2O2 by mitochondria, while compound 3 exhibited a pronounced antioxidant effect on glutamate/malate-driven respiration and, on the other hand, caused ROS overproduction when organelles are energized with succinate. All tested compounds exhibited surface-active properties, reducing the fluidity of mitochondrial membranes and contributing to nonspecific permeabilization of the lipid bilayer of mitochondrial membranes and swelling of the organelles. Modified levopimaric acid diene adducts also induced nonspecific permeabilization of unilamellar lecithin liposomes, which confirmed their membranotropic properties. We discuss the mechanisms of action of the tested compounds on the mitochondrial OXPHOS system and the state of the lipid bilayer of membranes, as well as the prospects for the use of new modified levopimaric acid diene adducts in medicine.